Literature DB >> 20358202

Etanercept treatment in patients with rheumatoid arthritis on dialysis.

Tadashi Nakamura1, Syu-Ichi Higashi, Kunihiko Tomoda, Michishi Tsukano, Kenzi Arizono, Takamichi Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20358202     DOI： 10.1007/s00296-010-1452-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  8 in total

1.  Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis.

Authors:  M Nakamura; T Sakemi; K Nagasawa
Journal:  J Rheumatol       Date:  1999-06       Impact factor: 4.666

2.  Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.

Authors:  Howard Lee; Hui C Kimko; Mark Rogge; Diane Wang; Ivan Nestorov; Carl C Peck
Journal:  Clin Pharmacol Ther       Date:  2003-04       Impact factor: 6.875

3.  Anti-TNF treatment in secondary amyloidosis.

Authors:  V Ortiz-Santamaria; M Valls-Roc; M Sanmartí; A Olive
Journal:  Rheumatology (Oxford)       Date:  2003-11       Impact factor: 7.580

4.  Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.

Authors:  M Hammoudeh
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

5.  Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.

Authors:  A M Yee; M B Pochapin
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

6.  Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis.

Authors:  Ranju Singh; Raquel Cuchacovich; Wenqun Huang; Luis R Espinoza
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

7.  The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.

Authors:  Burl R Don; Gregory Spin; Ivan Nestorov; Matt Hutmacher; Aubri Rose; George A Kaysen
Journal:  J Pharm Pharmacol       Date:  2005-11       Impact factor: 3.765

8.  Use of etanercept in a patient with rheumatoid arthritis on hemodialysis.

Authors:  Yuko Sugioka; Kentaro Inui; Tatsuya Koike
Journal:  Mod Rheumatol       Date:  2008-02-27       Impact factor: 3.023
  8 in total
  1 in total

1.  The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis.

Authors:  Wenhong Wang; Shihe Shao; Zhijun Jiao; Mingquan Guo; Huaxi Xu; Shengjun Wang
Journal:  Rheumatol Int       Date:  2011-01-11       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.